Univest
Univest
  • Markets

Everest Organics (EVERESTO) Share Price Rises 9.38% to Rs 249

  • October 5, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Everest Organics Share Price
Everest Organics Ltd. (EVERESTO) share price rose to Rs 249 today, up 9.38% from the previous close. Market cap was Rs 227.05 crore.

Everest Organics Share Price is in focus after the stock traded at Rs 249, up 9.38% from the previous close of Rs 227.65. Everest Organics Ltd. now has a market capitalisation of Rs 227.05 crore, placing the move squarely on the radar of investors tracking Everest Organics Share Price Today and Everest Organics Stock News. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. That keeps the emphasis on what the numbers show: a higher intraday quote, a wider trading band and a valuation profile that is worth reading alongside Healthcare sector benchmarks. For investors following Everest Organics Share Price, the next checks are the day’s range, the company’s P/E, P/B, ROE, ROCE and how the stock compares with listed healthcare peers.

Table of Contents

Toggle
  • Everest Organics Share Price Today: Price Action Analysis
  • Everest Organics Ltd. (EVERESTO) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Everest Organics
  • About Everest Organics Ltd.
  • Frequently Asked Questions
    • What is Everest Organics Share Price today?
    • Why is Everest Organics Share Price rising today?
    • What was the day’s price movement in Everest Organics Share Price?
    • What is the market capitalisation of Everest Organics Ltd.?
    • What is Everest Organics Share Price valuation on P/E and P/B?
    • How do ROE and ROCE look for Everest Organics Share Price?
    • What do EPS, book value and dividend yield show for Everest Organics Share Price?
    • How does Everest Organics Share Price compare with listed peers?
  • Track Everest Organics Share Price on Univest

Everest Organics Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 249
Previous Close Rs 227.65
Today's Move Rs 21.35 (+9.38%)
Open Rs 229.95
High Rs 253
Low Rs 224.05
Market Capitalisation Rs 227.05 crore
Market Cap Category Micro Cap

Everest Organics Ltd. (EVERESTO) rose to Rs 249 from the previous close of Rs 227.65, a move of Rs 21.35 or 9.38%. The stock opened at Rs 229.95, reached a high of Rs 253, recorded a low of Rs 224.05.

Everest Organics Share Price Today shows a clear intraday gain. The stock opened at Rs 229.95, moved to a high of Rs 253 and a low of Rs 224.05, and was last trading at Rs 249 at 19 October 2026 at 10:52:41 AM IST. That places Everest Organics Share Price Rs 21.35 above the previous close, with the move visible across the day’s range rather than at a single print. The current market capitalisation of Rs 227.05 crore keeps Everest Organics Share Price in the small-company segment only where such a category is not needed; here, the exact market capitalisation is the more useful reference. For readers tracking Everest Organics Share Price Live, the main question is not just the rise itself, but what the broader financial metrics say around it. That leads directly into Everest Organics Fundamental Analysis.

Everest Organics Ltd. (EVERESTO) Fundamental Analysis

Metric Value
Market Capitalisation Rs 227.05 crore
P/E Ratio 43.21x
P/B Ratio 2.82x
ROE -2.25%
ROCE 1.76%
EPS Rs 5.27
Book Value Per Share Rs 80.8
Dividend Yield 0%

Everest Organics Ltd. (EVERESTO) fundamental metrics show P/E 43.21x, P/B 2.82x, ROE -2.25%, ROCE 1.76%. These figures provide context only and are not a buy or sell signal.

Everest Organics Ltd. has a market capitalisation of Rs 227.05 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 43.21x, P/B at 2.82x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -2.25% and ROCE of 1.76%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.27, book value per share of Rs 80.8, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.95x, median ROE of 10.96%, median ROCE of 13.01%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 43.21x
Benchmark Median P/E 30.95x
Benchmark Average P/E 46.82x
Benchmark P/E Range 3.1x to 629.67x
Company P/B Ratio 2.82x
Benchmark Median P/B 2.82x
Company ROE -2.25%
Benchmark Median ROE 10.96%
Company ROCE 1.76%
Benchmark Median ROCE 13.01%
Company Market Capitalisation Rs 227.05 crore
Benchmark Median Market Cap Rs 720.23 crore

Everest Organics Ltd. (EVERESTO) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Everest Organics Ltd. (EVERESTO) has a P/E ratio of 43.21x, which is above the benchmark median of 30.95x, a difference of +39.61%. On its own, the P/E gap is a valuation reference point, not a trading call.

Everest Organics Ltd. (EVERESTO) has a ROE of -2.25%, which is below the benchmark median of 10.96%, a difference of -120.53%. Everest Organics Ltd. (EVERESTO) has a ROCE of 1.76%, which is below the benchmark median of 13.01%, a difference of -86.47%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,22,282.95 34.91 4.88 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,44,762.03 83.68 13.86 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,73,447.74 79.53 19.32 26.76 19.27
Zydus Lifesciences Ltd. ZYDUSLIFE 1,12,149.36 24.85 4.16 19.69 21.39
Laurus Labs Ltd. LAURUSLABS 1,11,250.29 101.75 19.73 18.31 18.2

Everest Organics Ltd. (EVERESTO) has a P/E ratio of 43.21x compared with the displayed peer median of 79.53x. This peer read is a relative benchmark rather than a trading signal. Its ROE of -2.25% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 1.76% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Everest Organics Ltd. (EVERESTO) has a market capitalisation of Rs 227.05 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Everest Organics

  • Everest Organics Share Price is trading higher today, with the move reaching Rs 249 from a previous close of Rs 227.65.
  • Everest Organics Share Price Today is being read alongside a market capitalisation of Rs 227.05 crore.
  • Everest Organics Stock News is now tied to a P/E of 43.21 and a P/B of 2.82.
  • Everest Organics Fundamental Analysis shows ROE at -2.25% and ROCE at 1.76%.
  • Everest Organics Share Price also sits within the Healthcare and Pharmaceuticals & Drugs benchmark set.

About Everest Organics Ltd.

Everest Organics Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is identified in the market through its listed equity, market capitalisation and valuation ratios, which are followed by investors tracking Everest Organics Share Price, Everest Organics Share Price Today and Everest Organics Stock Analysis. the latest Univest figures show a business profile that can be read through earnings per share, book value, P/B ratio, P/E ratio, ROE and ROCE rather than through broad claims. Everest Organics Share Price matters in this context because it reflects how the market is valuing the company against its own financial ratios and against peer companies in the same industry. For readers watching Everest Organics Latest News, the stock’s place within Pharmaceuticals & Drugs makes sector comparison especially relevant, since valuation and return metrics vary widely across the peer set.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is Everest Organics Share Price today?

Ans. Everest Organics Share Price is Rs 249, which is 9.38% higher than the previous close of Rs 227.65. The move also leaves the company with a market capitalisation of Rs 227.05 crore as of 19 October 2026 at 10:52:41 AM IST.

Why is Everest Organics Share Price rising today?

Ans. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. Everest Organics Share Price is therefore best read through the day’s move, the intraday range and the company’s valuation ratios.

What was the day’s price movement in Everest Organics Share Price?

Ans. Everest Organics Share Price moved from a previous close of Rs 227.65 to Rs 249, a gain of Rs 21.35 or 9.38%. The stock also traded between Rs 224.05 and Rs 253 during the day.

What is the market capitalisation of Everest Organics Ltd.?

Ans. Everest Organics Ltd. has a market capitalisation of Rs 227.05 crore. That figure places Everest Organics Share Price below the same-industry median market capitalisation of Rs 720.23 crore in the benchmark set.

What is Everest Organics Share Price valuation on P/E and P/B?

Ans. Everest Organics Share Price is supported by a P/E ratio of 43.21 and a P/B ratio of 2.82. The P/E is above the same-industry median of 30.95, while the P/B matches the benchmark median of 2.82.

How do ROE and ROCE look for Everest Organics Share Price?

Ans. Everest Organics Share Price has ROE of -2.25% and ROCE of 1.76%. Both are below the benchmark median for the same industry, which helps explain why investors may compare it closely with peers.

What do EPS, book value and dividend yield show for Everest Organics Share Price?

Ans. Everest Organics Share Price comes with EPS of Rs 5.27, book value of Rs 80.8 and dividend yield of 0. EPS shows earnings per share, book value shows accounting net worth per share, and dividend yield is nil.

How does Everest Organics Share Price compare with listed peers?

Ans. Everest Organics Share Price has a higher P/E than Zydus Lifesciences and lower returns than several peers such as Lupin, Torrent Pharmaceuticals and Zydus Lifesciences. The peer set gives the stock useful valuation context.

Track Everest Organics Share Price on Univest

Use Everest Organics Ltd. (EVERESTO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Everest Organics Share Price on Univest to follow the latest quote, market capitalisation, valuation ratios, 52-week levels and company context in one place. Users can also review Everest Organics Share Price Today alongside peer comparison and sector data for quicker reference. For investors following Everest Organics Share News, Univest keeps the focus on facts that matter to stock analysis and fundamental analysis.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply